Literature DB >> 34476477

Molecular genetic evaluation of pediatric renovascular hypertension due to renal artery stenosis and abdominal aortic coarctation in neurofibromatosis type 1.

Dawn M Coleman, Yu Wang, Min-Lee Yang, Kristina L Hunker, Isabelle Birt, Ingrid L Bergin, Jun Z Li, James C Stanley, Santhi K Ganesh.   

Abstract

The etiology of renal artery stenosis (RAS) and abdominal aortic coarctation (AAC) causing the midaortic syndrome (MAS), often resulting in renovascular hypertension (RVH), remains ill-defined. Neurofibromatosis type 1 (NF-1) is frequently observed in children with RVH. Consecutive pediatric patients (N = 102) presenting with RVH secondary to RAS with and without concurrent AAC were prospectively enrolled in a clinical data base, and blood, saliva and operative tissue, when available, were collected. Among the 102 children, 13 were having a concurrent clinical diagnosis of NF-1 (12.5%). Whole exome sequencing was performed for germline variant detection, and RNA-Seq analysis of NF1, MAPK pathway genes and MCP1 levels were undertaken in five NF-1 stenotic renal arteries, as well as control renal and mesenteric arteries from children with no known vasculopathy or NF-1. In 11 unrelated children with sequencing data, 11 NF1 genetic variants were identified, of which 10 had not been reported in gnomAD. Histologic analysis of NF-1 RAS specimens consistently revealed intimal thickening, disruption of the internal elastic lamina and medial thinning. Analysis of transcript expression in arterial lesions documented an approximately 5-fold reduction in NF1 expression, confirming heterozygosity, MAPK pathway activation and increased MCP1 expression. In summary, NF-1-related RVH in children is rare but often severe and progressive and, as such, important to recognize. It is associated with histologic and molecular features consistent with an aggressive adverse vascular remodeling process. Further research is necessary to define the mechanisms underlying these findings.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2022        PMID: 34476477      PMCID: PMC8825256          DOI: 10.1093/hmg/ddab241

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   5.121


  40 in total

1.  The anatomy of the posterior wall of the abdominal aorta. Its significance with regard to hypoplasia of the distal aorta.

Authors:  R S Arnot; J H Louw
Journal:  S Afr Med J       Date:  1973-06-02

2.  Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1?

Authors:  M H Cnossen; M N van der Est; M H Breuning; C J van Asperen; E J Breslau-Siderius; A T van der Ploeg; A de Goede-Bolder; A M van den Ouweland; D J Halley; M F Niermeijer
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

Review 3.  Insights into the pathogenesis of neurofibromatosis 1 vasculopathy.

Authors:  S J Hamilton; J M Friedman
Journal:  Clin Genet       Date:  2000-11       Impact factor: 4.438

4.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

5.  Abdominal aortic coarctation: surgical treatment of 53 patients with a thoracoabdominal bypass, patch aortoplasty, or interposition aortoaortic graft.

Authors:  James C Stanley; Enrique Criado; Jonathan L Eliason; Gilbert R Upchurch; Ramon Berguer; John E Rectenwald
Journal:  J Vasc Surg       Date:  2008-08-09       Impact factor: 4.268

6.  Genetics of renovascular hypertension in children.

Authors:  Daan H H M Viering; Melanie M Y Chan; Lieke Hoogenboom; Daniela Iancu; Jeroen H F de Baaij; Kjell Tullus; Robert Kleta; Detlef Bockenhauer
Journal:  J Hypertens       Date:  2020-10       Impact factor: 4.844

7.  A framework for variation discovery and genotyping using next-generation DNA sequencing data.

Authors:  Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly
Journal:  Nat Genet       Date:  2011-04-10       Impact factor: 38.330

Review 8.  Emerging genotype-phenotype relationships in patients with large NF1 deletions.

Authors:  Hildegard Kehrer-Sawatzki; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2017-02-17       Impact factor: 4.132

9.  NF1 mutation drives neuronal activity-dependent initiation of optic glioma.

Authors:  Michelle Monje; David H Gutmann; Yuan Pan; Jared D Hysinger; Tara Barron; Nicki F Schindler; Olivia Cobb; Xiaofan Guo; Belgin Yalçın; Corina Anastasaki; Sara B Mulinyawe; Anitha Ponnuswami; Suzanne Scheaffer; Yu Ma; Kun-Che Chang; Xin Xia; Joseph A Toonen; James J Lennon; Erin M Gibson; John R Huguenard; Linda M Liau; Jeffrey L Goldberg
Journal:  Nature       Date:  2021-05-26       Impact factor: 69.504

10.  Identification of Mutation Regions on NF1 Responsible for High- and Low-Risk Development of Optic Pathway Glioma in Neurofibromatosis Type I.

Authors:  Min Xu; Hui Xiong; Yanfang Han; Chijun Li; Shaozhen Mai; Zhongzhou Huang; Xuechen Ai; Zhixuan Guo; Fanqin Zeng; Qing Guo
Journal:  Front Genet       Date:  2018-07-24       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.